TLR1
Toll-like receptor 1
Also known as: CD281, KIAA0012, rsc786, TLR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15399
- Gene
- TLR1
- Ensembl
- ENSG00000174125
- Chromosome
- 4
- Canonical length
- 786 aa
- Protein class
- CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
786 residues, UniProt reviewed canonical sequence.
>Q15399|TLR1
1 MTSIFHFAII FMLILQIRIQ LSEESEFLVD RSKNGLIHVP KDLSQKTTIL NISQNYISEL
61 WTSDILSLSK LRILIISHNR IQYLDISVFK FNQELEYLDL SHNKLVKISC HPTVNLKHLD
121 LSFNAFDALP ICKEFGNMSQ LKFLGLSTTH LEKSSVLPIA HLNISKVLLV LGETYGEKED
181 PEGLQDFNTE SLHIVFPTNK EFHFILDVSV KTVANLELSN IKCVLEDNKC SYFLSILAKL
241 QTNPKLSNLT LNNIETTWNS FIRILQLVWH TTVWYFSISN VKLQGQLDFR DFDYSGTSLK
301 ALSIHQVVSD VFGFPQSYIY EIFSNMNIKN FTVSGTRMVH MLCPSKISPF LHLDFSNNLL
361 TDTVFENCGH LTELETLILQ MNQLKELSKI AEMTTQMKSL QQLDISQNSV SYDEKKGDCS
421 WTKSLLSLNM SSNILTDTIF RCLPPRIKVL DLHSNKIKSI PKQVVKLEAL QELNVAFNSL
481 TDLPGCGSFS SLSVLIIDHN SVSHPSADFF QSCQKMRSIK AGDNPFQCTC ELGEFVKNID
541 QVSSEVLEGW PDSYKCDYPE SYRGTLLKDF HMSELSCNIT LLIVTIVATM LVLAVTVTSL
601 CSYLDLPWYL RMVCQWTQTR RRARNIPLEE LQRNLQFHAF ISYSGHDSFW VKNELLPNLE
661 KEGMQICLHE RNFVPGKSIV ENIITCIEKS YKSIFVLSPN FVQSEWCHYE LYFAHHNLFH
721 EGSNSLILIL LEPIPQYSIP SSYHKLKSLM ARRTYLEWPK EKSKRGLFWA NLRAAINIKL
781 TEQAKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TLR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 32 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 32 nTPM
- appendix: 25 nTPM
- spleen: 24 nTPM
- tonsil: 19 nTPM
- lymph node: 15 nTPM
- lung: 10 nTPM
Single-cell type
- neutrophils: 547 nCPM
- microglia: 201 nCPM
- kupffer cells: 160 nCPM
- macrophages: 98 nCPM
- cdc: 71 nCPM
- monocytes: 64 nCPM
Immune cell
- neutrophil: 129 nTPM
- non-classical monocyte: 43 nTPM
- intermediate monocyte: 31 nTPM
- classical monocyte: 22 nTPM
- myeloid DC: 14 nTPM
- total PBMC: 9 nTPM
Brain region
- white matter: 16 nTPM
- medulla oblongata: 13 nTPM
- thalamus: 11 nTPM
- spinal cord: 10 nTPM
- midbrain: 9.1 nTPM
- pons: 9.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TLR1.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 152 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.7
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to triacyl bacterial lipopeptide
- detection of triacyl bacterial lipopeptide
- immune response
- inflammatory response
- innate immune response
- macrophage activation
- microglial cell activation
- positive regulation of interleukin-6 production
- positive regulation of interleukin-8 production
- positive regulation of toll-like receptor 2 signaling pathway
- positive regulation of tumor necrosis factor production
- signal transduction
- toll-like receptor signaling pathway
Molecular functions
- identical protein binding
- lipopeptide binding
- signaling receptor activity
- Toll-like receptor 2 binding
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Toll/interleukin-1 receptor homology (TIR) domain
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Toll-like receptor
- Leucine-rich repeat domain superfamily
- Toll/interleukin-1 receptor homology (TIR) domain superfamily
- Leucine rich repeat C-terminal domain
- TIR domain
- Leucine rich repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TLR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TLR1 as an antibody target. Whether an autoantibody or antibody against TLR1 could matter depends on whether native TLR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TLR1 is annotated at the cell surface, where native TLR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TLR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...